UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Fulton Bank N.A.

Fulton Bank N.A. lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,874 shares of the healthcare conglomerate’s stock after acquiring an additional 577 shares during the quarter. Fulton Bank N.A.’s holdings in UnitedHealth Group were worth $6,188,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in UNH. Axiom Financial Strategies LLC acquired a new position in shares of UnitedHealth Group during the 1st quarter valued at $210,000. McGowan Group Asset Management Inc. increased its stake in UnitedHealth Group by 8.9% during the 1st quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock worth $379,000 after buying an additional 61 shares during the period. Mirae Asset Global Investments Co. Ltd. boosted its position in UnitedHealth Group by 31.8% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock valued at $127,592,000 after buying an additional 60,300 shares during the last quarter. MAS Advisors LLC boosted its position in UnitedHealth Group by 10.8% in the 1st quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock valued at $241,000 after buying an additional 45 shares during the last quarter. Finally, First Western Trust Bank purchased a new position in UnitedHealth Group in the 1st quarter valued at about $875,000. Institutional investors and hedge funds own 85.69% of the company’s stock.

Analysts Set New Price Targets

UNH has been the subject of a number of analyst reports. Wells Fargo & Company decreased their price objective on shares of UnitedHealth Group from $616.00 to $561.00 in a research report on Thursday, July 13th. StockNews.com started coverage on shares of UnitedHealth Group in a research note on Thursday, August 17th. They issued a “buy” rating on the stock. JPMorgan Chase & Co. upped their target price on shares of UnitedHealth Group from $527.00 to $532.00 and gave the company an “overweight” rating in a research note on Monday, July 17th. HSBC assumed coverage on shares of UnitedHealth Group in a research note on Wednesday, September 6th. They issued a “hold” rating and a $540.00 target price on the stock. Finally, Stephens reiterated an “overweight” rating and set a $560.00 price objective on shares of UnitedHealth Group in a research note on Friday, August 11th. Two research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $575.65.

UnitedHealth Group Trading Up 0.6 %

Shares of NYSE:UNH opened at $486.70 on Friday. The stock has a market capitalization of $450.83 billion, a price-to-earnings ratio of 21.78, a PEG ratio of 1.42 and a beta of 0.66. UnitedHealth Group Incorporated has a 1-year low of $445.68 and a 1-year high of $558.10. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.80 and a current ratio of 0.80. The company has a 50 day moving average price of $491.55 and a 200 day moving average price of $486.55.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Friday, July 14th. The healthcare conglomerate reported $6.14 earnings per share for the quarter, topping analysts’ consensus estimates of $5.92 by $0.22. The firm had revenue of $92.90 billion during the quarter, compared to analysts’ expectations of $90.97 billion. UnitedHealth Group had a net margin of 6.06% and a return on equity of 26.72%. The firm’s revenue for the quarter was up 15.6% compared to the same quarter last year. During the same period last year, the firm posted $5.57 earnings per share. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 24.83 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Monday, September 11th will be given a $1.88 dividend. The ex-dividend date is Friday, September 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.65%.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CEO Andrew Witty sold 4,000 shares of the stock in a transaction that occurred on Wednesday, July 19th. The shares were sold at an average price of $506.19, for a total value of $2,024,760.00. Following the completion of the sale, the chief executive officer now owns 78,573 shares in the company, valued at approximately $39,772,866.87. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.35% of the stock is owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.